References
- Gough A, Barsoum NJ, Mitchell L, McGuire EJ, de la Iglesia FA. Juvenile canine drug induced arthropathy: clinicopathological studies on articular lesions caused by oxolinic and pipemidic acids. Toxicol Appl Pharmacol 1979;51:177-87 https://doi.org/10.1016/0041-008X(79)90020-6
- Christ W, Lehnert T, Ulbrich B. Specific toxicologic aspects of the quinolones. Rev Infect Dis 1988;10(Suppl 1):141-6 https://doi.org/10.1093/clinids/10.Supplement_1.S141
- Schluter G. Ciprofloxacin: toxicologic evaluation of additional safety data. Am J Med 1989;87(Suppl 5A):37-9 https://doi.org/10.1016/S0002-9343(89)80927-1
- Hooper DC, Rubinstein E. Quinolone Antimicrobial Agents. 3rd ed. Washington, DC: ASM Press; 2003
- Capparelli EV, Reed MD, Bradley JS, Keams GL, Jacohs RF, Damie BD et al. Pharmacokinetics of gatifloxacin in infants and children. Antimicrob Agents Chemother 2005; 49:1106-12 https://doi.org/10.1128/AAC.49.3.1106-1112.2005
- Leibovitz E, Dagan R, Blumer J. Pharmacokinetics of levofloxacin in plasma and middle ear fluid of infants and young children (page 1, abstractA-6). 43th Interscience. Conference on Antimicrobial Agents and Chemotherapy; 30 October-2 November; Washington, DC. 2004
- Ho PL, Que TL, Chiu SS, Yung RW, Ng TK, Tsang DN et al. Fluoroquinolone and other antimicrobial resistance. Emerg Infect Dis 2004;10:1250-7 https://doi.org/10.3201/eid1007.030612
- Doern GV, Richter SS, Miller A, Miller N, Rice C, Heilmann K, et al. Antimicrobial Resistance among Streptococcus pneumoniae in the United States: Have We Begun to Turn the Corner on Resistance to Certain Antimicrobial Classes? Clin Infect Dis 2005;41:139-48 https://doi.org/10.1086/430906
- Reinert RR, Reinert S, Linden M, Cil MY, Al-Lahham A, Appelbaum P. Antimicrobial susceptibility of Strep pneumo in eight European countries. Antimicrob Agents Chemother 2005;49:2903-13 https://doi.org/10.1128/AAC.49.7.2903-2913.2005
- Davidson R, Cavalcanti R, Brunton JL, Bast DJ, Azavedo JCS, Kibsey P, et al. Resistance to levofloxacin and failure of treatment of pneumococal pneumonia. N Engl J Med 2002;346:747-50 https://doi.org/10.1056/NEJMoa012122
- Mandell LA, Peterson LR, Wise R, Hooper D, Low DE, Schaad UB, et al. The battle against emerging antibiotic resistance: Should Fluoroquinolones Be Used to Treat Children? Clin Infect Dis 2002;35:721-7 https://doi.org/10.1086/341900
- Schaad UB, Stoupis C, Wedgwood J, Tsch-aeppeler H, Vock P. Clinical, radiologic and mag-netic resonance monitoring for skeletal toxi-city in pediatric patients with cystic fibrosis re-ceiving a three-month course of ciprofloxacin. Pediatr Infect Dis J 1991;10:723-9
- Burkhardt JE, Walterspiel JN, Schaad UB. Quinolone arthopathy in animals versus children. Clin Infect Dis 1997;25: 1196-204 https://doi.org/10.1086/516119
- Chalumeau M, Tonnelier S, D'Athis P, Treluyer JM, Gendrel D, Breart G, et al. Fluoroquinolone safety in pediatric patients: a prospective, multi-center, comparative cohort study in France. Pediatrics 2003;111(6 Pt 1):e714-9 https://doi.org/10.1542/peds.111.6.e714
- Drossou-Agakidou V, Roilides E, Papakyriakidou-Koliouska P, Agakidis C, Nikolaides N, Sarafidis K et al. Use of ciprofloxacin in neonatal sepsis: lack of adverse effects up to one year. Pediatr Infect Dis J 2004;23:34-9
- Hampel B, Hullmann R, Schmidt H. Ciproflox-acin in pediatrics: worldwide clinical experience based on compassionate use-safety report. Pediatr Infect Dis J 1997;16:127-9 https://doi.org/10.1097/00006454-199701000-00036
- Gendrel D, Chalumeau M, Moulin F, Raymond J. Fluoroquinolones in paediatrics: a risk for the patient or for the community community? The Lancet In-fectious Diseases 2003;3:537-46 https://doi.org/10.1016/S1473-3099(03)00736-9
- Petrilli AS, Dantas LS, Campos MC, Tanaka C, Ginani VC, Seber A. Oral ciprofloxacin vs. intra-venous ceftriaxone administered in an out-patient setting for fever and neutropenia in low-risk pe-diatric oncology patients: randomized prospective trial. Med Pediatr Oncol 2000;34:87-91 https://doi.org/10.1002/(SICI)1096-911X(200002)34:2<87::AID-MPO2>3.0.CO;2-F
- Thaver D, Zaidi AK, Critchley J, Madni SA, Bhutta ZA. Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev 2005:CD004530
- Moulin F, Sauve-Martin H, Marc E, Lorrot MM, Soulier M, Ravilly S, et al. Ciprofloxacin after clinical failure of betalactam antibiotics in chil-dren with salmonellosis. Arch Pediatr 2003;10:608-14 https://doi.org/10.1016/S0929-693X(03)00281-1
- Vinh H, Duong NM, Phuong LT, Truong NT, Bay PV, Wain J, et al. Comparative trial of short-course ofloxacin for uncomplicated typhoid fever in Vietnamese children. Ann Trop Paediatr 2005;25:17-22 https://doi.org/10.1179/146532805X23308
- Leibovitz E, Janco J, Piglansky L, Press J, Yagupsky P, Reinhart H, et al. Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children. Pediatr Infect Dis J 2000;19:1060-7 https://doi.org/10.1097/00006454-200011000-00006
- Guerin PJ, Brasher C, Baron E, Mic D, Grimont F, Ryan M, et al. Case management of a multi-drug-resistant Shigella dysenteriae sero-type 1 out-break in a crisis context in Sierra Leone, 1999-2000. Trans R Soc Trop Med Hyg 2004; 98:635-43 https://doi.org/10.1016/j.trstmh.2004.01.005
- Gendrel D, Chalumeau M, Moulin F, Raymond J. Fluoroquinolones in paediatrics: a risk for the patient or for the community? Lancet Infect Dis 2003;3:537-46 https://doi.org/10.1016/S1473-3099(03)00736-9
- Cizman M, Orazem A, Kriza-Hergouth V, Kolman J. Correlation between increased consumption of fluoroquinolones in outpatients and resistance of Escherichia coli from urinary tract infections. J Antimicrob Chemother 2001;47:502-3 https://doi.org/10.1093/jac/47.4.502
- Pichichero ME, Arguedas A, Dagan R, Sher L, Saez-Llorens X, Hamed K, et al. Safety and efficacy of gatifloxacin therapy for children with recurrent acute otitis media (AOM) and/or AOM treatment failure. Clin Infect Dis J 2005;41: 470-8. https://doi.org/10.1086/431584
- Noel GJ, Leibovitz E, Dagan R. Levofloxacin therapy for infants and young children with persistent or recurrent acute otitis media (page 267, abstract G-2081). 43th Interscience Conference on Antimicrobial Agents and Chemotherapy; 30 October-2 November. 2004
- Sabella C. Management of otorrhea in infants and children. Pediatr Infect Dis J 2000;19:1007-8 https://doi.org/10.1097/00006454-200010000-00014
- Krcmery V Jr, Filka J, Uher J, Kurak H, Sagat T, Tuharsky J, et al. Ciprofloxacin in treatment of nosocomial meningitis in neonates and in infants: report of 12 cases and review. Diagn Microbiol Infect Dis 1999;35:75-80 https://doi.org/10.1016/S0732-8893(99)00052-8
Cited by
- Antibiotic Sensitivity Patterns in Children with Urinary Tract Infection: Retrospective Study Over 8 Years in a Single Center vol.23, pp.1, 2008, https://doi.org/10.3339/jkspn.2019.23.1.22